
ABSTRACT Caring for a child with atopic dermatitis (AD) places strain on parents, but it remains unclear whether additional atopic comorbidities or psychosocial context compounds this burden. Data from the 2007–2008 National Survey of Children's Health among 6913 children aged 6–17 years was analyzed using survey‐weighted multivariable regression to examine associations between a 5‐item parental strain scale and parent‐reported AD severity, comorbid asthma, allergic rhinitis, and food allergy, along with family, social, and healthcare access factors. Increased parental strain was associated with AD severity and with delayed or forgone care. Decreased parental strain was associated with better maternal mental health and with the female sex of the child. Atopic comorbidities were not associated with strain. Parental strain was more strongly associated with psychosocial factors and the severity of AD than the presence of additional atopic comorbidities.
ABSTRACT Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome is a rare autoinflammatory disease with a paradoxical relationship with systemic isotretinoin, which has been described both as a possible trigger and as a therapeutic agent for the severe acne component. We present a 17‐year‐old male with longstanding acne conglobata who developed bilateral sacroiliitis and sternal osteitis shortly after initiation of systemic isotretinoin, with findings supported by whole‐body bone scintigraphy and SPECT/CT. Following stabilization of the disease, low‐dose isotretinoin was cautiously reintroduced for persistent severe acne without recurrence of musculoskeletal symptoms. This case highlights the paradoxical role of isotretinoin in SAPHO syndrome: although it may trigger or unmask osteoarticular involvement, it can be cautiously reintroduced after adequate inflammatory control in carefully selected patients with persistent severe acne.
ABSTRACT Narrowband UVB phototherapy (nbUVB) is an important first‐line therapy in the management of vitiligo. We conducted a cross‐sectional study of offices of board‐certified dermatologists in Washington state to assess the availability of in‐office nbUVB for the treatment of vitiligo in children. Of 129 offices identified as offering phototherapy, 46/129 (35.7%) offered phototherapy for vitiligo, 42/46 (91.3%) treated children, and only 18/42 (42.9%) accepted Medicaid insurance, with counties with the highest rates of pediatric Medicaid coverage having no in‐office phototherapy options. This study highlights geographic and financial barriers to care in pediatric vitiligo and the need for a more comprehensive method for patients to identify in‐office phototherapy, and potentially highlights a role for home phototherapy units in pediatric care.
Background/Objectives Injection pain and needle-related anxiety may limit acceptance and continuation of biologic therapy in children with atopic dermatitis (AD). Real-world data on injection pain during nemolizumab treatment is limited. We aimed to longitudinally quantify injection pain during nemolizumab treatment under standardized vibration-and-cooling analgesia and evaluate early clinical outcomes.Methods This retrospective observational cohort study enrolled children aged 6-12 years with moderate-to-severe AD who had completed 16 weeks of nemolizumab treatment (30 mg every 4 weeks) between June 2024 and July 2025. All injections were administered with standardized vibration-and-cooling analgesia. Injection pain was assessed immediately after each injection using the Wong-Baker FACES Pain Rating Scale (0-10). Secondary outcomes included the Peak Itch Numeric Rating Scale (NRS), Patient-Oriented Eczema Measure (POEM), and Eczema Area and Severity Index (EASI) scores.Results The 13 children provided 62 of 65 planned pain ratings. Injection pain was consistently minimal (median 0; interquartile range [IQR] 0-2); no child reported severe pain (score >= 8). At Week 16, the median EASI reduction was 87.5% (IQR, 73.7-90.3); EASI-75 was achieved by 9 of 13 (69.2%) participants. Median peak itch NRS improved by 5.0 points (IQR, 3.0-6.0), and median POEM improved by 7.0 points (IQR, 4.0-12.0). No serious adverse events occurred.Conclusion Under standardized vibration-and-cooling analgesia, nemolizumab administration was associated with minimal injection pain and substantial early clinical improvement; these findings do not represent the intrinsic injection pain of nemolizumab without analgesia.
Bibliotherapy in pediatric dermatology can be a useful tool for addressing the emotional and social impact of skin conditions in children. Current publication trends across 110 children's books on eczema, birthmarks, vitiligo, alopecia, psoriasis, ichthyosis, and acne show that the number of publications, eBook availability, and skin of color representation has increased over the last 20 years. However, this progress is not evenly distributed across ages or diagnoses. Future published works could be geared towards adolescents and discuss less commonly represented skin conditions like ichthyosis, acne, and alopecia. Additional work is also needed to assess the impact of bibliotherapy in children with skin disease.